Tomás P. Carroll

3.4k total citations
59 papers, 2.0k citations indexed

About

Tomás P. Carroll is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomás P. Carroll has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cancer Research, 25 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomás P. Carroll's work include Protease and Inhibitor Mechanisms (31 papers), Peptidase Inhibition and Analysis (23 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Tomás P. Carroll is often cited by papers focused on Protease and Inhibitor Mechanisms (31 papers), Peptidase Inhibition and Analysis (23 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Tomás P. Carroll collaborates with scholars based in Ireland, United States and Canada. Tomás P. Carroll's co-authors include Noel G. McElvaney, Shane O’Neill, Catherine M. Greene, Clifford C. Taggart, James Devaney, Emer P. Reeves, Oliver J. McElvaney, Catherine O’Connor, Alessandro N. Franciosi and Emer Kelly and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Tomás P. Carroll

52 papers receiving 2.0k citations

Peers

Tomás P. Carroll

PRM

ONCOL

IMMUN

Shadi Swaidani United States

Seema S. Dalal United States

Katarzyna Bulek United States

Geneviève Paulissen Belgium

Christine T. N. Pham United States

Tadashi Osaki Japan

Katie Streicher United States

Azzaq Belaaouaj France

Sandra van Wetering Netherlands

Daniel L. Worthley Australia

Shadi Swaidani United States

Tomás P. Carroll

305 ×0.4

239 ×0.3

PRM

631 ×1.2

451 ×0.9

ONCOL

1.4k ×3.5

IMMUN

Citations per year, relative to Tomás P. Carroll Tomás P. Carroll (= 1×) peers Shadi Swaidani

Countries citing papers authored by Tomás P. Carroll

Since Specialization

Citations

This map shows the geographic impact of Tomás P. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás P. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás P. Carroll more than expected).

Fields of papers citing papers by Tomás P. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomás P. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás P. Carroll. The network helps show where Tomás P. Carroll may publish in the future.

Co-authorship network of co-authors of Tomás P. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Tomás P. Carroll. A scholar is included among the top collaborators of Tomás P. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomás P. Carroll. Tomás P. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pai, Shweta, Ashok Muniappan, Aaron D. Friedman, et al.. (2024). 992O Pembrolizumab for HPV-associated recurrent respiratory papillomatosis. Annals of Oncology. 35. S676–S676. 2 indexed citations

McCarroll, Kevin, et al.. (2024). Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review. Osteoporosis International. 35(7). 1299–1302. 2 indexed citations

Ottaviani, Stefania, Tomás P. Carroll, Fabrizio Gangemi, et al.. (2023). Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency. American Journal of Respiratory Cell and Molecular Biology. 69(3). 355–366. 5 indexed citations

Carroll, Tomás P., et al.. (2023). Family Screening in Severe Alpha-1 Antitrypsin Deficiency - Too Little, Too Late? An Argument for Newborn Screening. A1571–A1571.

Carroll, Tomás P., et al.. (2023). CPC01 A puzzling panniculitis. British Journal of Dermatology. 188(Supplement_4).

McElvaney, Oliver J., Brian Cleary, Oisín F. McElvaney, et al.. (2023). Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 11(1). 3–12. 3 indexed citations

Stephenson, Aoife, et al.. (2023). Physical Activity, Exercise Capacity and Sedentary Behavior in People with Alpha-1 Antitrypsin Deficiency: A Scoping Review. International Journal of COPD. Volume 18. 1231–1250.

Hogan, Grace, Pierce Geoghegan, Tomás P. Carroll, et al.. (2021). α1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome?. Anesthesiology. 134(5). 792–808. 7 indexed citations

Franciosi, Alessandro N., Brian D. Hobbs, Oliver J. McElvaney, et al.. (2020). Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 202(1). 73–82. 28 indexed citations

10.

Reeves, Emer P., Danielle M. Dunlea, Tomás P. Carroll, et al.. (2019). Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity. The Journal of Immunology. 202(8). 2240–2253. 17 indexed citations

11.

Dandurand, Ronald J., Tomás P. Carroll, Raúl San Jośe Estépar, Jean Bourbeau, & David H. Eidelman. (2014). Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD. European Respiratory Journal. 44(Suppl 58). P4780–P4780. 1 indexed citations

12.

Molloy, Kevin, Craig P. Hersh, Valerie B. Morris, et al.. (2014). Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α1-Antitrypsin Deficiency PiMZ Heterozygotes. American Journal of Respiratory and Critical Care Medicine. 189(4). 419–427. 118 indexed citations

13.

Hassan, Tidi, Tomás P. Carroll, Patrick G. Buckley, et al.. (2013). miR-199a-5p Silencing Regulates the Unfolded Protein Response in Chronic Obstructive Pulmonary Disease and α1-Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 189(3). 263–273. 64 indexed citations

14.

Kelly, Emer, Catherine M. Greene, Tomás P. Carroll, Noel G. McElvaney, & Shane O’Neill. (2011). Alpha-1 antitrypsin deficiency. Respiratory Medicine CME. 4(1). 1–8. 11 indexed citations

15.

Carroll, Tomás P., et al.. (2010). Evidence for Unfolded Protein Response Activation in Monocytes from Individuals with α-1 Antitrypsin Deficiency. The Journal of Immunology. 184(8). 4538–4546. 94 indexed citations

16.

Kelly, Emer, Catherine M. Greene, Tomás P. Carroll, Noel G. McElvaney, & Shane O’Neill. (2010). Alpha-1 antitrypsin deficiency. Respiratory Medicine. 104(6). 763–772. 58 indexed citations

17.

Kelly, Emer, Catherine M. Greene, Tomás P. Carroll, Noel G. McElvaney, & Shane O’Neill. (2009). Selenoprotein S/SEPS1 Modifies Endoplasmic Reticulum Stress in Z Variant α1-Antitrypsin Deficiency. Journal of Biological Chemistry. 284(25). 16891–16897. 59 indexed citations

18.

Greene, Catherine M., Tomás P. Carroll, Stephen G. J. Smith, et al.. (2005). TLR-Induced Inflammation in Cystic Fibrosis and Non-Cystic Fibrosis Airway Epithelial Cells. The Journal of Immunology. 174(3). 1638–1646. 182 indexed citations

19.

Devaney, James, Catherine M. Greene, Clifford C. Taggart, et al.. (2003). Neutrophil elastase up‐regulates interleukin‐8 via toll‐like receptor 4. FEBS Letters. 544(1-3). 129–132. 192 indexed citations

20.

Carroll, Tomás P., et al.. (1995). The Dandy-Walker Syndrome - A 10-Year Experience of its Management and Outcome. European Journal of Pediatric Surgery. 5(S 1). 16–18. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact